These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 17363596)
1. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596 [TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900 [TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Lee AH; Hong JH; Seo YS Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836 [TBL] [Abstract][Full Text] [Related]
6. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha. Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902 [TBL] [Abstract][Full Text] [Related]
8. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation. Griffin BD; Moynagh PN Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530 [TBL] [Abstract][Full Text] [Related]
9. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Hiroi M; Ohmori Y Biochem J; 2003 Dec; 376(Pt 2):393-402. PubMed ID: 12946268 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446 [TBL] [Abstract][Full Text] [Related]
11. Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway. Feng G; Ohmori Y; Chang PL Carcinogenesis; 2006 Jan; 27(1):43-52. PubMed ID: 16000401 [TBL] [Abstract][Full Text] [Related]
12. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Huang YH; Wu JY; Zhang Y; Wu MX Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408 [TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB. Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830 [TBL] [Abstract][Full Text] [Related]
14. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270 [TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Thornburg NJ; Pathmanathan R; Raab-Traub N Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988 [TBL] [Abstract][Full Text] [Related]
16. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes. Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370 [TBL] [Abstract][Full Text] [Related]
17. Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Tran TT; Segev DL; Gupta V; Kawakubo H; Yeo G; Donahoe PK; Maheswaran S Mol Endocrinol; 2006 Oct; 20(10):2382-91. PubMed ID: 16740653 [TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Bobrovnikova-Marjon EV; Marjon PL; Barbash O; Vander Jagt DL; Abcouwer SF Cancer Res; 2004 Jul; 64(14):4858-69. PubMed ID: 15256456 [TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines. Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Reuter S; Schnekenburger M; Cristofanon S; Buck I; Teiten MH; Daubeuf S; Eifes S; Dicato M; Aggarwal BB; Visvikis A; Diederich M Biochem Pharmacol; 2009 Feb; 77(3):397-411. PubMed ID: 18996094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]